Cascadian Therapeutics (CASC)

[lecorb]

A sell signal for these stocks: Oncothyreon Inc (USA) (NASDAQ:ONTY), Avago Technologies Ltd (NASDAQ:AVGO), Delcath Systems, Inc. (NASDAQ:DCTH)

Developed J. Welles Wilder, the Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI is an extremely popular momentum indicator that has been featured in a number of articles, interviews and books over the years. In particular, Constance Brown’s book, Technical Analysis for the Trading Professional, features the concept of bull market and bear market ranges for RSI. Andrew Cardwell, Brown’s RSI mentor, introduced positive and negative reversals for RSI. In addition, Cardwell turned the notion of divergence, literally and figuratively, on its head.

RSI oscillates between zero and 100. Traditionally, and according to Wilder, RSI is considered overbought when above 70 and oversold when below 30. Signals can also be generated by looking for divergences, failure swings and centerline crossovers. RSI can also be used to identify the general trend.

Oncothyreon Inc (USA) (NASDAQ:ONTY) is now in overbought territory with an RSI value of 77.56. The stock is up +106.13% in one month through last close, to $3.36, showing a +108.70% return during the past three months. The share price is up from fifty two week low with +138.30% and low from fifty two week high with -6.67%. It stands +86.65% above the average-price of 50 days and +72.22% compared with the SMA 20.

Avago Technologies Ltd (NASDAQ:AVGO) has a RSI reading of 74.14, with a 1-year total return of +102.35% and a six-month return of +57.88%. The stock is up +17.76% in one month through last close, to $141.49, showing a +25.94% return during the past three months. The share price is up from fifty two week low with +108.03% and up from fifty two week high with +3.82%. It stands +12.65% above the average-price of 50 days and +14.07% compared with the SMA 20.

Delcath Systems, Inc. (NASDAQ:DCTH) currently has an RSI of 79.90. The stock is up +39.22% in one month through last close, to $1.42, showing a +19.33% return during the past three months. The share price is up from fifty two week low with +77.50% and low from fifty two week high with -52.67%. It stands +48.26% above the average-price of 50 days and +62.94% compared with the SMA 20.
http://www.wsobserver.com/a-sell-signal-for-these-stocks-oncothyreon-inc-usa-nasdaqonty-avago-technologies-ltd-nasdaqavgo-delcath-systems-inc-nasdaqdcth/7216402/

The main Chart in shorted.This chart is very important for an investor.

http://stockcharts.com/freecharts/gallery.html?s=ONTY